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AbstrAct
We aimed at describing antimicrobial usage patterns 
throughout livestock production cycles, and comparing 
them across three countries from Northern, Central and 
Southern Europe. Given the difficulties to collect such 
detailed usage data, an expert opinion was deemed the 
most appropriate study design. This study provides new 
insights into the time periods and indications for which 
specific antimicrobial substances are used in different 
livestock sectors.
Veterinary experts (n=67) from different livestock sectors 
(broilers, pigs, dairy cattle and veal/fattening calves) and 
countries (Denmark, Portugal and Switzerland) replied 
to a questionnaire focusing on the time periods in the 
production cycle when antimicrobial substances were 
administered, and the respective indications for treatment.
Our results showed that for several antimicrobials, 
between-country and within-country variations exist 
regarding the temporal distributions of treatments and 
indications for use. These differences were also true 
for several critically important antimicrobials, which is 
a matter of concern. Furthermore, differences between 
countries were also evident regarding the antimicrobial 
substances licensed.
Based on our results, it is recommended to establish and 
promote treatment guidelines, invest in the prevention of 
diseases during critical moments of the production cycle 
and target undifferentiated use of antimicrobials. Moreover, 
discrepancies between countries should be further 
investigated to better understand the factors underlying 
the identified patterns and to distinguish prudent from 
non-prudent use. The results can inform decision-making 
with the aim to foster antimicrobial prudent use in the 
veterinary setting and, therefore, protect public health from 
the threat of antimicrobial resistance.
IntroduCtIon
Antimicrobial resistance is nowadays a 
topic of much discussion and of undeni-
able relevance for public health.1–3 Part of 
the resistance burden in humans is attrib-
utable to antimicrobial use (AMU) in live-
stock production, however its contribution 
has not yet been quantified.4 5 To preserve 
the efficacy of these substances, prudent 
AMU in human and veterinary medicine is 
widely advocated.6 7 Moreover, authorities are 
promoting a reduction of AMU in the veter-
inary field both at the national and interna-
tional levels.2 8–11 
A profound understanding of the under-
lying drivers and reasons of AMU in livestock 
production is fundamental for a successful 
reduction of antimicrobial consumption 
without jeopardising animal health, welfare 
and productivity. Nevertheless, comparison 
of AMU across countries has often been 
limited to comparing the total amount of 
active substance per animal population, 
because detailed data on AMU are only avail-
able for few countries. A key aspect that has 
not been thoroughly investigated relates to 
the patterns of use of specific antimicrobial 
substances. These patterns harbour essential 
information about how, when and for which 
reasons veterinarians use these compounds. 
Such patterns can also provide an insight on 
educational aspects, animal health issues, 
management practices, private standards or 
legislative regulations that need to be further 
considered in awareness-raising campaigns or 
in the identification of targeted measures. A 
better understanding of AMU patterns is of 
help to pinpoint specific factors that should 
be addressed by interventions, such as the 
development of inexpensive, easy-to-use 
vaccines or, disease eradication.
Furthermore, it is known that AMU esti-
mates based on sales data vary greatly across 
Europe, in terms of the overall amounts sold 
per kilogram of animal biomass, and in the 
relative use of different antimicrobial classes 
and routes of administration.12 13 Poten-
tial dissimilarities in the patterns of AMU 
(eg, using a given substance for different 
copyright.
 o
n
 16 O
ctober 2018 by guest. Protected by
http://vetrecordopen.bmj.com/
Vet R
ec O
pen: first published as 10.1136/vetreco-2018-000288 on 11 Septem
ber 2018. Downloaded from
 
Open access
2 Carmo LP, et al. Vet Rec Open 2018;5:e000288. doi:10.1136/vetreco-2018-000288
indications or at different time points of the production 
cycle) should partly explain these variations.
The role of veterinarians on AMU is of central impor-
tance. First, the prescribing responsibility lies with the 
veterinarian. Secondly, veterinary practitioners often 
advise producers on farm management practices, 
including biosecurity and vaccination strategies that 
might have an impact in animal health and, therefore, 
affect AMU at the farm level. Hence, harvesting the 
knowledge acquired through practical work experience 
in specific livestock production systems from specialised 
veterinarians provides an opportunity to gain insights into 
AMU and reasons for specific AMU patterns in livestock.
The objectives of this study were to: (1) investigate 
the temporal AMU patterns throughout the produc-
tion cycles and the indications for specific antimicrobial 
substances, within each of four common livestock sectors; 
(2) to compare the results obtained between the coun-
tries. The findings of this study shall allow us to identify 
potential targets for interventions to foster prudent AMU 
in livestock.
MaterIals and Methods
Collecting such detailed data on AMU patterns and 
indications for treatment would be very difficult. There-
fore, an expert opinion study was considered the most 
appropriate design. Veterinarians enrolled in this study 
were based in Denmark, Portugal and Switzerland, and 
declared clinical expertise and practical experience in 
at least one of the following livestock sectors: broilers, 
pigs, dairy cattle or veal/fattening calves. The selection 
of these countries allowed the inclusion of a Northern, 
Central and Southern European country, as well as coun-
tries with different levels of antimicrobial sales (below 
European average: Denmark and Switzerland; above 
European average: Portugal).12 The production cycle of 
fattening calves (slaughtered around 10–12 months of 
age) was targeted in Denmark and Portugal. For Swit-
zerland, veterinarians with experience in the veal calf 
industry (animals slaughtered around six months of age) 
were contacted, due to the importance of this production 
system and its contribution to the overall antimicrobial 
consumption in the country.14
Participants
University departments working on animal production 
and clinics, as well as veterinarians and farmers’ associ-
ations, were contacted to identify potential participants, 
who were regarded as being particularly knowledgeable 
about animal health and AMU in the sector. Moreover, 
enrolled veterinarians were asked to suggest additional 
participants. This process, the so-called ‘snowball’ nomi-
nation, is frequently used to create an expert panel.15 
We aimed to have between five and nine experts in each 
stratum, as this was previously described as an accept-
able size for expert panels. Panel sizes can be extended 
when experts are inquired separately, but given the 
characteristics of the questionnaire and the difficulties 
to find adequate participants we limited the number of 
experts to the above-mentioned range.15
Participating veterinarians were asked to provide 
answers considering the AMU practices in the country. 
All experts were assured anonymity. 
Questionnaire
Questionnaires were prepared in English using MS 
Excel16 and consisted of the following structures:
1. Personal details—with emphasis on the professional 
activity of the participants.
2. Patterns of usage—this part was replicated for all the 
substances and was further subdivided into the follow-
ing sections:
a. Pattern of usage in sows versus fattening pigs—this 
question only targeted pig experts with the objec-
tive of estimating the relative proportion of treat-
ments in sows compared with fattening pigs.
b. Pattern of usage at the age class level—experts were 
asked to indicate the relative proportion of treat-
ments for given age classes (eg, piglets, weaners, 
finishers for pig production; calves, heifers, dairy 
cows for cattle production). These age classes cor-
responded to a certain range of days, which were 
defined a priori through expert consultation. These 
periods varied slightly between countries due to 
country-specific production characteristics (eg, ear-
lier weaning in Danish pig production). Details on 
the age class definitions can be found in the web ap-
plication created to present the results of the study 
(https:// lpgcarmo. shinyapps. io/ eeii/).
c. Indications at the age class level—experts were 
asked to indicate the relative proportions of treat-
ments for different organ systems for the age class-
es described above. The organ system list included: 
gastrointestinal, mammary gland, musculoskeletal, 
neurological, reproductive, respiratory, septicae-
mia/multiple organs, skin/ocular and urinary.
d. Pattern of usage for specific age periods—for pigs, 
dairy cattle and fattening calves (Denmark and Por-
tugal) four time intervals were developed within 
each age class. These age periods were determined 
a priori through expert consultation and varied 
slightly between countries. Experts were asked to 
give the relative proportion of treatments for each 
one of these periods.
It should be stressed that questions on the patterns 
and indications for treatment focused on the amount 
of treatment performed rather than the amount of 
antimicrobials used.
To determine which active pharmaceutical ingredients 
(hereafter called substances) should be investigated in 
each country/livestock sector, data were collected on the 
substances licensed per country/animal species.17–19 Oral 
and parenteral substances were considered separately. 
Due to the high number of available active ingredients, 
β-lactamase sensitive penicillins were grouped under 
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‘penicillins’. In addition, sulfonamides and trimethoprim 
products were grouped under ‘sulfonamides/trimetho-
prim’. Lincomycin and spectinomycin were considered 
together irrespectively of being present in an individual 
or combination product. Finally, substances subjected 
to restrictions on use in Denmark (fluoroquinolones 
and third/fourth-generation cephalosporins) were not 
included in the questionnaire for Danish experts due to 
their limited use.20 For dairy cattle, two distinct catego-
ries were created for lactation and drying-off treatments. 
In these two categories, the pattern of AMU was deter-
mined irrespectively of the substances.
Questionnaires were pretested with four experts (one 
for each livestock sector) in September 2015. As no major 
modifications were suggested, three completed pretesting 
questionnaires were included in the analysis. The fourth 
expert who participated in the pretesting provided oral 
feedback, thus, no answers were used in the analysis.
The data collection took place between October 2015 
and March 2016. Potential experts were contacted and 
if they agreed to participate, detailed information about 
the study was provided and the questionnaires were sent 
via electronic mail. Reminders followed around one and 
two months after the questionnaire was initially sent. 
Experts were rewarded with a bottle of wine (Portugal 
and Switzerland) or a gift card (Denmark). The question-
naires are available in the web application.
analysis
Data management and preparation for analysis was 
conducted in MS Excel.16 Data were analysed with the 
statistical software R, V.3.3.1.21
When returned questionnaires included missing 
values, experts were contacted to provide the values at 
fault. In case experts did not reply to this request, incom-
plete entries were imputed using the following rule: (A) 
for numerical variables, the answers of experts from that 
country for that same substance were used to calculate 
the mean; (B) for categorical variables, the most common 
answer from experts from that country for that same 
substance was introduced. If an expert did not reply any 
question for a given substance, no values were imputed. 
Incomplete entries were only imputed when the expert 
replied to the questions for a given substance, but certain 
values were missing.
The proportion of treatments per age class or age 
period was summarised for each combination of 
country/livestock sector/substance using the mean of 
the estimates from the participating experts. Experts who 
did not provide any answers to a given substance were 
excluded from the mean calculation of that substance.
Given that age classes and age periods represented 
time intervals of different lengths, results were also 
summarised as the relative percentage of treatments per 
day. This was calculated by dividing the mean proportion 
of treatment of an age period by the length of the age 
period in days.
  Prtx/daya =
∑ Prtx aexpert 1+Prtx aexpert 2+...+Prtx aexpert n
n
da   
Prtx/day: proportion of treatments per day; a: a given age 
period; n: number of experts answering the question; d: 
duration of a given time period.
Results on the indications for treatment were 
summarised per age class and as a total (for all age classes), 
by calculating the mean of the estimates provided by the 
experts.
To be able to visualise the results interactively and 
for the entire set of country/livestock sector/substance 
combinations, a web application was developed using 
the R package ‘Shiny’.22 It can be accessed through the 
following link: https:// lpgcarmo. shinyapps. io/ eeii/.
results
experts’ information
The median number of years of clinical experience of 
participating veterinarians was 17 (IQR: 10–25). The 
percentage of participants working at university insti-
tutes was 19 per cent. In addition, 40 per cent of the 
respondents worked in mixed practices, meaning that 
they conducted clinical work with more than one animal 
species.
Six of the 67 participants (four Danish veterinar-
ians—two from dairy, one from pig and one from the 
fattening calf industry—and two Portuguese veteri-
narians—one from the broiler and one from the pig 
industry) were not practising clinical veterinary medi-
cine when this study was conducted. The answers from 
these experts were still included in the analysis because 
of the participants’ prior extensive clinical expertise. 
Moreover, their professional activities (related to live-
stock production and animal health) allowed these 
experts to have an up-to-date overview on national 
production practices.
Product availability
The antimicrobial substances authorised for each live-
stock species varied between the countries (for details 
see web application). It should be noted that due to 
the grouping of certain substances and the elimina-
tion of substances with use limimations in Denmark, 
the presented values should only be interpreted as an 
approximation of the total number of active pharmaceu-
tical ingredients licensed in each country.
For broilers, Switzerland only had four substances 
licensed (one of them was licensed but not available on 
the Swiss market) while in Denmark and Portugal, 10 and 
16 substances were licensed, respectively. In the other 
livestock sectors, fewer combinations of substances/route 
of administration were licensed in Denmark (dairy: 23, 
fattening calves: 24, pigs: 26) compared with Switzerland 
(dairy: 29, veal calves: 29, pigs: 30) and Portugal (dairy: 
33, fattening calves: 33, pigs: 34).
copyright.
 o
n
 16 O
ctober 2018 by guest. Protected by
http://vetrecordopen.bmj.com/
Vet R
ec O
pen: first published as 10.1136/vetreco-2018-000288 on 11 Septem
ber 2018. Downloaded from
 
Open access
4 Carmo LP, et al. Vet Rec Open 2018;5:e000288. doi:10.1136/vetreco-2018-000288
aMu patterns and indications
Overall, 0.4 per cent of numerical values and 0.1 per cent 
of categorical values were imputed.
The proportion of experts replying to the questions for 
each substance varied between countries/livestock sectors 
(Table 1). Treatment patterns and indications for all the 
substances can be consulted in the web application.
Broilers
Oral sulfonamides/trimethoprim products are an 
example for which the treatment pattern was similar 
between the countries. Overall, there were more 
substances with a uniform pattern of use across age 
classes in Portugal than in the other two countries.
Differences between Portugal and Switzerland on the 
distribution and indication of oral enrofloxacin treat-
ments were observed: in Switzerland, the majority of 
the treatments occurred in the first week and targeted 
‘septicaemia/multiple organs’; while in Portugal the 
treatments were distributed rather uniformly over all 
age classes, with other indications also being considered 
(Fig 1). The variability in the answers of Swiss experts 
was smaller when compared with the Portuguese ones. 
‘Septicaemia/Multiple Organs’ indication varied from a 
minimum of 97 per cent to a maximum of 100 per cent 
of oral enrofloxacin treatments. For that same indica-
tion, the estimates from Portuguese experts ranged from 
0 to 87 per cent. Gastrointestinal treatments (minimum: 
0 per cent; maximum: 29 per cent) and respiratory treat-
ments (minimum: 14 per cent; maximum: 59 per cent) 
were also considered by Portuguese experts as frequent 
indications for the use of oral enrofloxacin in broilers.
Pigs
With respect to the proportion of treatments of sows 
versus fattening pigs (piglets, weaners and finishers), 
only few disparities were observed between countries. 
However, differences between the results for Portugal 
and Switzerland regarding the use of fluoroquinolones 
and third/fourth-generation cephalosporins deserve 
attention (Fig 2). In Portugal, the proportion of treat-
ments in fattening pigs was higher than in Switzerland. It 
should also be noted that the variability of answers within 
each country was large.
For most substances, treatment incidences peaked in 
the beginning of a production phase (first time period 
as piglet, weaner or finisher). Oral colistin constitutes 
an example: the pattern between the countries showed 
some similarities, peaking in the first time period in the 
weaning phase (Fig 3).
The patterns of use of tetracycline substances also 
showed some similarities between countries. For chlor-
tetracycline, both for Denmark and Switzerland, experts 
indicated that the majority of treatments occurred during 
the weaner stage. Nonetheless, it should be noted that 
Danish experts estimated a more uniform use during this 
production period, while Swiss participants considered 
that most treatments happened in the first 11 days after 
weaning. The treatment peak with parenteral oxytetra-
cycline was estimated to happen in the beginning of the 
finisher stage in the three countries. However, for oral 
oxytetracycline treatments peaked in different produc-
tion stages: in Denmark, most treatments occurred in 
the beginning of the weaner phase, whereas in Portugal 
the treatment peak happened at the start of the finisher 
phase.
Differences between Portugal and Switzerland with 
respect to the pattern of cephalosporins (parenteral 
ceftiofur) and fluoroquinolones (parenteral enroflox-
acin and parenteral marbofloxacin) were observed. In 
general, the treatment pattern in Portugal was more 
uniformly distributed across the production cycle than 
in Switzerland, where it tended to peak in the first 
TABLE 1: The proportion of experts answering the patterns and indications for use of each substance was 
calculated. Results stratified per livestock sector/country are  summarised  in the table using the median,  25 %  quantile  and  
75 %  quantile . 
Livestock sector Country
Licensed 
substances (n) Median (%) 25% quantile (%) 75% quantile (%)
Total number 
of experts
Broilers Denmark 10 67 42 100 3
Broilers Portugal 16 75 50 100 4
Broilers Switzerland 4 83 58 100 3
Pigs Denmark 26 100 88 100 6
Pigs Portugal 34 71 61 100 7
Pigs Switzerland 31 56 38 75 8
Dairy cattle Denmark 26 100 65 100 5
Dairy cattle Portugal 35 86 71 100 7
Dairy cattle Switzerland 31 75 56 100 8
Fattening calves Denmark 24 63 31 75 4
Fattening calves Portugal 33 71 57 86 7
Veal calves Switzerland 29 60 40 80 5
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week of life. Some discrepancies on the treatment indi-
cations were also observed. Parenteral cefquinome 
is an example: in Portugal, most treatments targeted 
gastrointestinal diseases (mean: 52 per cent; minimum: 
27 per cent, maximum: 80 per cent), while in Switzer-
land musculoskeletal problems were the main indication 
(mean: 87 per cent; minimum: 68 per cent, maximum: 
97 per cent). Parenteral marbofloxacin constitutes 
another illustration: according to the experts, it is not 
used for respiratory diseases in Switzerland (mean: 
0 per cent; minimum: 0 per cent, maximum: 0 per cent), 
contrarily to what was suggested by Portuguese experts 
(mean: 49 per cent; minimum: 0 per cent, maximum: 
100 per cent).
Dairy cattle
For most substances, the majority of treatments occurred 
either during the calf phase or during the first period of 
lactation. Most mastitis treatments occurred in the first 
2.5 months of lactation and no major differences in the 
pattern of AMU were detected between the countries.
The pattern of use of parenteral penicillins was similar 
between the three countries, with most treatments occur-
ring during the adult phase of the animals. However, it 
should be noted that the relative proportion of treat-
ments in Denmark during the calf and heifer phases was 
lower than in Portugal and Switzerland. With regard to 
the pattern of use of oral sulfonamides/trimethoprim, 
it is interesting to note that Swiss participants expected 
some of the treatments to occur after the calf phase; this 
was not indicated by Danish and Portuguese experts. 
Furthermore, the peak of treatments in Denmark and 
Portugal was estimated to happen in the first week of life, 
whereas in Switzerland it would occur later.
Regarding the indications of treatment during the 
calf phase, some differences were observed. For several 
substances (oral amoxicillin, parenteral danofloxacin 
and parenteral enrofloxacin) respiratory treatments had 
a higher preponderance in Switzerland than in Denmark 
and Portugal, where gastrointestinal indications had a 
higher importance.
Veal/fattening calves
When compared with Danish experts, Portuguese veter-
inarians estimated a higher relative proportion of treat-
ments in steers with certain substances, such as oral 
formulations of tilmicosin and tylosin, or parenteral 
formulations of florfenicol, gamithromycin, tildipirosin 
FIG 1: Indications for oral treatment with enrofloxacin in broilers. The proportion of treatments for each indication is depicted 
in different colours. Bars indicate the mean relative proportion of treatments with oral enrofloxacin in different age classes of 
the production cycle. n, number of answers.
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and tulathromycin. In these cases, the main indication 
for treatment in steers was respiratory disease.
For oral tylosin, the vast majority of calf treatments in 
Denmark were estimated to target gastrointestinal disease 
(mean: 90 per cent, minimum: 80 per cent, maximum: 
100 per cent). In Portugal and Switzerland, the respiratory 
indication dominated the use of this substance in calves 
(Portugal—mean: 78 per cent, minimum: 45 per cent, 
maximum: 100 per cent; Switzerland—mean: 94 per cent, 
minimum: 79 per cent, maximum: 100 per cent). Differ-
ences between countries were observed regarding the indi-
cations of parenteral cefquinome and danofloxacin. For 
the latter, Swiss experts estimated a higher proportion of 
respiratory treatments in calves than Portuguese experts; 
for parenteral cefquinome a similar finding was detected, 
when comparing Switzerland with Denmark and Portugal.
dIsCussIon
This expert opinion study demonstrates differences in the 
consumption patterns of antimicrobials in three European 
countries. These variations are evident in the timing, as well 
as in the indication of treatment for particular substances. 
Within-country variability was also observed, implying that 
there are differences in the pattern of AMU even within the 
same livestock sector/country.
Potential explanations for differences observed between the 
countries
Several factors can influence the indications and patterns 
of AMU and, therefore, contribute to the differences 
observed between the countries. Overall, these can be 
divided into three categories: (A) animal health and 
farm management; (B) socioeconomic factors; and (C) 
policy/market factors.
Disease prevalence and predisposing management prac-
tices/farming conditions are obvious factors to consider 
when interpreting the differences observed between the 
countries. An example of influencing management prac-
tices is animal transportation. For instance, veal calves 
in Switzerland are generally transported to a fattening 
farm between 25 and 35 days of age. This practice might 
explain the peak in the relative proportion of treatments 
with several substances in the age segment (7–60 days) 
that includes the above-mentioned period. Moreover, 
for multiple antimicrobials respiratory treatments were 
the primary indication in Swiss cattle, while in the other 
countries gastrointestinal problems prevailed. This might 
FIG 2: Mean proportion of treatments between sows and fattening pigs for parenteral use of cefquinome, ceftiofur and 
enrofloxacin. Points represent individual expert answers. n, number of answers.
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reflect differences in the prevalence of specific animal 
health problems and could therefore provide grounds to 
prioritise prevention/control measures.
Multiple socioeconomic factors can influence AMU. 
Veterinarians’ education might have an implication on 
the prescription practices11 and preference of practi-
tioners for certain substances. The same experts who 
participated in this study were also asked to score poten-
tial measures to reduce the use of antimicrobials in 
livestock. Improving veterinarian’s education was consid-
ered as an impactful and feasible intervention for that 
purpose.23 Furthermore, the experience of veterinar-
ians is often considered an important factor that shapes 
patterns of AMU.24–27 We hypothesise that, together with 
education, this could be a reason why most participants 
did not provide answers to all the substances included 
in the questionnaires (Table 1). Veterinarians might rely 
on a series of products that they use for specific diseases, 
without considering all available options. This reflects the 
need to further investigate and understand the impact of 
education on the prescription practices of veterinarians 
and guarantee that a similar level of awareness is attained, 
both in the undergraduate education and in the contin-
uous education of European veterinarians.
On the policy/market side, it should be noted that 
product availability differs between countries and could 
also contribute to the variation in use patterns and indi-
cations observed in this study. The fact that only four 
antimicrobial substances are licensed for use in the Swiss 
broiler sector is an example of a restriction in substance 
availability that can potentially influence the choices 
of veterinarians. The Danish restrictions on the use of 
fluoroquinolones and third/fourth-generation cephalo-
sporins is another example.28 29 The Weighted Animal 
Daily Doses strategy implemented as part of the Danish 
Yellow card benchmarking system—which allocates 
higher importance to third/fourth-generation cephalo-
sporins, fluoroquinolones, colistin and tetracyclines—
also constitutes an illustration of a policy that shapes 
the pattern of use of substances by influencing the selec-
tion of antimicrobials to be prescribed.30 Product prices 
can also influence veterinarians’ preferences, given 
FIG 3 Mean proportion of treatments with oral colistin across the pig production cycle. Bars indicate the mean relative 
proportion of treatments with oral colistin in different age periods of the production cycle. Points represent individual expert 
answers. n, number of answers.
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that economic aspects often drive decisions in livestock 
farming.27 31 However, no information on the price differ-
ences between countries could be collected.
It is already known that the level of AMU, as well as the 
relative consumption of different antimicrobial classes 
and the preference for given routes of administration 
vary between countries.12 13 This can contribute to the 
variability between countries observed in our results, 
regarding the AMU temporal patterns and indications. 
In a comparison between antimicrobial consumption in 
Denmark and Switzerland, the largest difference in anti-
microbial consumption (measured in mg/kg of biomass), 
both for pigs and cattle, was observed for sulfonamides/
trimethoprim.13 In our results, it was also possible to 
observe differences between the two countries on the 
temporal distribution and indication for treatments 
with these substances. With the exception of adult dairy 
cattle, the vast majority of treatments with sulfonamides/
trimethoprim in Denmark were specified for gastrointes-
tinal problems, while in Switzerland, other indications 
were also considered.
study limitations
Expert opinion is often used for modelling purposes,32 33 
as well as to get an insight on stakeholders’ perspective 
over a topic.34–36 Expert opinion is an accepted method 
when data are unavailable or difficult to collect. Never-
theless, interpretation of the results should take into 
account that only a small knowledgeable sample of the 
population is being inquired. A limited number of partic-
ipating experts might hamper adequate inferences about 
the true situation in the country and, therefore, extrapo-
lations should be done with caution.
For the majority of the country/livestock sector 
strata, the number of experts was within the acceptable 
range.15 The recommended minimum number (5) of 
broiler experts fell short (Denmark: 3, Portugal: 4, Swit-
zerland: 3). Nonetheless, it should be stressed that due 
to the centralised structure of the broiler production 
system in Europe, few veterinarians are responsible for 
the largest part of the countries’ production. This also 
implicates that practitioners from the same companies 
would provide similar answers, given the standardised 
procedures with respect to antimicrobial treatments. It 
should also be noted that experts were asked to answer 
the questionnaire based on the AMU practices in their 
country. However, their answers might have been biased 
by their personal experience.
Means were used to summarise the relative proportion 
of treatments in different age classes and age periods, 
even when the number of answers was limited and data 
were not normally distributed. Using medians, instead of 
means, could have resulted in proportions of treatments 
above or below 100 per cent in a production cycle.
Due to the large number of substances already included 
in the questionnaires, combination products and intra-
mammary preparations were not assessed separately. 
Moreover, the analysis was performed at the level of 
substance/route of administration. However, the pattern 
of usage might differ between products, namely if the 
substance concentration varies. This should not have a 
large influence on the results of this study; however, the 
potential for bias should be acknowledged.
Finally, indications for treatment were grouped into 
organ systems. In certain cases, the choice of organ system 
might not be straightforward, which can introduce some 
bias (eg, in broilers, certain diseases can progress from 
gastrointestinal manifestations to septicaemia). In addi-
tion, aggregating indications at the level of organ system 
might have eventually masked some within-country and 
between-country differences on the specific indications 
for treatment.
relevance and implications
Understanding the moment of use and the reason for 
treatment for each substance is an important piece 
of information that could support the development 
of tailored interventions to enhance prudent AMU 
and, thus, protect animal and public health. However, 
collecting detailed data on AMU patterns can be very 
challenging. Even automated systems, such as the Danish 
VetStat,37 collect data at the age class level, without 
further resolution.
Furthermore, the use of single standardised weights 
to calculate antimicrobial consumption has been shown 
to influence the results obtained.38 Combining the 
temporal patterns of treatment with weight distributions 
might enable a more precise calculation of AMU.
It should be stressed that no inferences can be made 
about the frequency of treatment, neither between 
substances nor between countries. This study focused 
on the distribution of treatments across the production 
cycle. No information was collected on the amount of 
antimicrobials used, and the results of this study were not 
combined with usage data. Nonetheless, in several occa-
sions it was possible to observe a rather uniform distribu-
tion of treatments of oral antimicrobials throughout the 
entire production cycle. Such a distribution might indi-
cate an undifferentiated or prophylactic AMU, which is 
undesirable and merits further investigation.
Due to the complexity of the topic and the characteris-
tics of the data collected in this study, limited inferences 
can be made about prudent use of antimicrobials. None-
theless, it is interesting to note that the first-line antimi-
crobials recommended by the Danish guidelines39 for 
treating common occurring gastrointestinal diseases in 
pigs were also suggested by the experts to be mainly used 
for gastrointestinal treatments. This, however, cannot 
guarantee that the guidelines are being followed, as indi-
cation data were collected at the organ system level and 
not at the pathogen level. Furthermore, the first-choice 
treatment was beyond the scope of the study. On the 
other hand, the large relative proportion of treatments 
with oral enrofloxacin in young Swiss broilers should be 
a matter of concern, given its negative effects on the bone 
and cartilage development.40 41 This might be related 
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to the limited antimicrobial options available for Swiss 
broiler veterinarians; it must therefore be guaranteed 
that enrofloxacin is not used as a first-line antimicrobial 
due to the lack of other options.
The variability on the temporal distribution and indica-
tion of treatments observed between and within countries 
suggests the need to develop and promote guidelines. 
These should always take into consideration the needs 
and the expertise of veterinary practitioners. The vari-
ability detected for critically important antimicrobials, as 
defined by the World Health Organization,42 is of partic-
ular concern given that these compounds are of rele-
vance for human medicine and should only be used in 
veterinary medicine as a last resource.
The distribution of treatments tended to peak in the 
beginning of the age periods, after animals were moved 
to a new production stage. This highlights the need to 
prevent AMU through specific measures (eg, reduced 
mixing of animals from different origins, promoting 
vaccination, improving biosecurity) to protect animals 
in those moments when their immunity is more 
compromised.
Lastly, the differences in the licensed substances in 
each country hamper a harmonised European strategy 
on the fight against AMU and antimicrobial resistance. 
Regulating antimicrobial licensing at European level 
might strengthen a common approach on the topic.
Despite the fact that this expert opinion study increases 
our knowledge about the allocation of antimicrobial treat-
ments, both regarding their temporal distribution and 
the indications for use, this approach should not be seen 
as an equivalent replacement for good-quality AMU data. 
The improvement of data collection systems for live-
stock antimicrobial consumption should be continuously 
fostered.
ConClusIons
To the best of our knowledge, this is the first time that 
AMU patterns are studied in such detail for a compre-
hensive set of substances. The between-country and 
within-country variations in the temporal patterns and 
indications for treatment reveal a need for treatment 
guidelines. Special attention should be given to criti-
cally important antimicrobials, by addressing the patho-
gens fostering their use and providing alternatives with 
similar levels of efficacy. Drivers of the observed differ-
ences (within and between countries) should be further 
investigated to elucidate tailored interventions that will 
boost prudent use. Moreover, targeted interventions 
to prevent the need for antimicrobials in the moments 
when livestock is particularly susceptible to disease are 
recommended.
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